Literature DB >> 9441786

Mechanisms of cardiac preconditioning: ten years after the discovery of ischemic preconditioning.

D R Meldrum1.   

Abstract

Cardiac preconditioning describes the phenomenon by which transient ischemia induces myocardial protection against subsequent ischemia and reperfusion injury. Ten years have passed since the original description of this potent cardiac protective strategy and within this period tremendous progress has been made elucidating the mechanisms of preconditioning. Mechanistic understanding may allow safe clinical application. This review (1) recalls the history of preconditioning and how it relates to the history of the investigation of endogenous adaptation; (2) summarizes the current mechanistic understanding of early preconditioning; (3) compares and contrasts the mechanisms of early versus delayed preconditioning; (4) suggests potential anti-inflammatory aspects of preconditioning; (5) examines limitations in laboratory models of preconditioning; and (6) explores the potential of using preconditioning clinically. Copyright 1997 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9441786     DOI: 10.1006/jsre.1997.5187

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  6 in total

Review 1.  If ischemic preconditioning is the gold standard, has a platinum standard of cardioprotection arrived? Comparison with NHE inhibition.

Authors:  R J Gumina; G J Gross
Journal:  J Thromb Thrombolysis       Date:  1999-07       Impact factor: 2.300

2.  Preconditioning protects against ischemia/reperfusion injury of the liver.

Authors:  B Nilsson; S Friman; B I Gustafsson; D S Delbro
Journal:  J Gastrointest Surg       Date:  2000 Jan-Feb       Impact factor: 3.452

3.  Fructose-1,6-biphosphate in rat intestinal preconditioning: involvement of nitric oxide.

Authors:  A Sola; J Roselló-Catafau; E Gelpí; G Hotter
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

4.  Protein kinase Cepsilon interacts with cytochrome c oxidase subunit IV and enhances cytochrome c oxidase activity in neonatal cardiac myocyte preconditioning.

Authors:  Mourad Ogbi; John A Johnson
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

Review 5.  Renal ischemia/reperfusion injury; from pathophysiology to treatment.

Authors:  Maryam Malek; Mehdi Nematbakhsh
Journal:  J Renal Inj Prev       Date:  2015-06-01

6.  An inhibitor of the δPKC interaction with the d subunit of F1Fo ATP synthase reduces cardiac troponin I release from ischemic rat hearts: utility of a novel ammonium sulfate precipitation technique.

Authors:  Mourad Ogbi; Ijeoma Obi; John A Johnson
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.